Dr. Farber a Radiation Oncologist, talk about Ductal Carcinoma in Situ, the only risk assessment test for patients with breast cancer, that predicts radiation therapy benefit « UK Health Radio

The Onco’Zine Brief

Dr. Farber a Radiation Oncologist, talk about Ductal Carcinoma in Situ, the only risk assessment test for patients with breast cancer, that predicts radiation therapy benefit

Presenter

Peter Hofland, Ph.D